Cycle on Jun 19, 2026

I am going to list the active threads for this topic to see what specific research questions or watches have been registered and need attention or resolution in this cycle.

I am going to read the existing notes for this topic to understand what has already been documented and to make sure I don't duplicate any findings unnecessarily, and to see if there are any active updates needed.

I see a lot of interesting topics. We are looking for what is *new* and has *changed* since the last cycle. The last cycle was around June 19, 2026. Let's do a search for recent news in science and health from the last week (or fresh news from June 12-19, 2026, and specifically June 19-20, 2026). Let's search the open web for recent major medical, clinical trial, FDA, and public health updates. Let's run a web search. I want to search for FDA approvals, clinical trial readouts, outbreaks, and breakthroughs. I'll search with `freshness="week"`. Let's do a few searches.I will search the web for recent major news in medicine, FDA approvals, and clinical trials from the last week to see what major developments have occurred.

Let's look at the results. 1. "U.S. FDA Accepts Gilead's Application for Investigational Once Weekly Oral Yeztugo, Potentially the First Long Acting Pill for HIV Prevention." Let's search for this news! This is a major development. Gilead's Yeztugo (lenacapavir) once weekly oral. Let's see the details. 2. "FDA Approves First Generic Version of Influenza Antiviral Baloxavir" (Xofluza). 3. "AbbVie Expands Blood Cancer Treatment Portfolio with New Clinical Data and Approvals" - FDA approval for DECNUPAZ? Let's check what DECNUPAZ (or similar) is. Let's search for "AbbVie DECNUPAZ" or "AbbVie blood cancer approval June 2026". 4. Let's look at "FDA Novel Drug Therapy Approvals for 2026": Ambelvist (gadoquatrane), Cypsedo (cipepofol), Xocova (ensitrelvir), Zaynich (cefepime and zidebactam)... Wait! Let's pull the list of FDA novel drug approvals for 2026 or search specifically for recent approvals in June 2026. Let's do some searches. First, let's search for "Gilead Yeztugo FDA acceptance" or similar. Second, let's search for "AbbVie blood cancer approval June 2026" or "DECNUPAZ". Third, let's search for "baloxavir marboxil generic FDA approval June 2026". Fourth, let's search for "ACTIV-6 trial metformin long COVID risk". Let's write queries for these. I will state my intent and execute.I will perform targeted searches on the FDA acceptance of Gilead's Yeztugo (lenacapavir) for HIV PrEP, the AbbVie blood cancer approval, and other recent major clinical/regulatory news.

Let's fetch the Gilead press release from EATG or Gilead itself to get the exact details. The URL `https://www.gilead.com/news/news-details/2026/u-s--fda-accepts-gileads-application-for-investigational-once-weekly-oral-yeztugo-potentially-the-first-long-acting-pill-for-hiv-prevention` or `https://www.eatg.org/hiv-news/press-release-fda-accepts-gileads-application-for-investigational-once-weekly-oral-yeztugo-potentially-the-first-long-acting-pill-for-hiv-prevention/` can be used. Let's do `web_fetch` on one of them. First, let's state the intent and call `web_fetch`.I will fetch the Gilead press release regarding the FDA acceptance of the sNDA for once-weekly oral Yeztugo (lenacapavir) for HIV PrEP. This is highly relevant to one of our active watches: "FDA regulatory decision on Gilead's once-weekly oral Yeztugo for HIV PrEP" (thread ID: 019ed29e-a6ae-790c-8ca3-dd606cdeec86).

This is a very clear and important update. The FDA accepted the sNDA on June 15, 2026, and assigned a PDUFA date of February 2, 2027. This directly relates to the existing thread: - **FDA regulatory decision on Gilead's once-weekly oral Yeztugo for HIV PrEP** (ID: `019ed29e-a6ae-790c-8ca3-dd606cdeec86`). Wait, let's look at the description of this thread: `Monitor the FDA regulatory decision on Gilead's supplemental New Drug Application (sNDA) for Yeztugo (lenacapavir) 300-mg tablets as a potential once-weekly oral formulation for HIV PrEP.` Wait, has this watch been triggered yet? The trigger is "Fires when the FDA grants or denies approval... (PDUFA date: February 2, 2027)". So the watch itself is for the decision, which is on Feb 2, 2027. But we should record that the FDA *accepted* the application, which solidifies the PDUFA date. Let's see if we have a separate finding or if we can update the existing note. Let's check our notes. The note `gilead-merck-lenacapavir-once-weekly-hiv-advances` exists. Let's check its content by searching for it or reading its revisions (wait, we already have its preview in `read_notes`). Let's search for "gilead-merck-lenacapavir-once-weekly-hiv-advances" or fetch it to see what's in there, then update it in place! Wait, let's first search the web for the other topics to see what else has happened in the last week. Let's search for "AbbVie blood cancer approval June 2026" or "DECNUPAZ". Let's search for "baloxavir marboxil generic FDA approval June 2026" or "generic Xofluza approval". Let's also search for other major FDA approvals or clinical trial readouts this week (June 12 to June 19, 2026). For example: - "FDA approval June 2026" - "Phase 3 clinical trial results June 2026" - "giredestrant" - "lurbinectedin" (Zepzelca) - "Amgen Tavneos" - "H5N1 bird flu" - "New World screwworm" Let's perform these searches. I will state my intent and execute.I will perform searches to investigate the AbbVie blood cancer drug approval (DECNUPAZ or similar), the generic Xofluza approval, and other recent major updates.

Wait, what is Decnupaz? Let's search for "Decnupaz FDA approval" or "Decnupaz AbbVie" or "Decnupaz blood cancer". Let's do a search on this. It seems Decnupaz is an AbbVie blood cancer treatment that recently got FDA approval, or maybe it is a newly approved drug. Let's find out what it is! Let's write a query for "Decnupaz".I will search for "Decnupaz" to find out what drug this is, its mechanism of action, what it was approved for, and when the FDA approved it.

Ah, Decnupaz (pivekimab sunirine-pvzy) was approved on May 27, 2026. This was slightly before our current window of "new since last cycle" (our last cycle was June 19, and the prior findings already have things from mid-June). So it is not brand-new, but let's check if there are other things that are more recent. Wait, let's search for the first generic of Xofluza (baloxavir marboxil). Let's search for "generic Xofluza FDA approval June 2026". Let's do a search.I will search for the FDA approval of the first generic of baloxavir marboxil (Xofluza) to see the details of this approval, including the manufacturer, the date of approval, and the significance.

This is an excellent, brand-new, and highly consequential science/health story. On June 17, 2026, the FDA approved the first generic version of Roche's Xofluza (baloxavir marboxil), which was granted to Norwich Pharmaceuticals Inc. Let's fetch the details of this story from one of these links, like `https://www.globenewswire.com/news-release/2026/06/18/3314199/0/en/fda-approves-first-single-dose-generic-treatment-for-influenza.html` or `https://www.reuters.com/business/healthcare-pharmaceuticals/fda-approves-first-generic-version-roches-flu-drug-2026-06-17/` to write a comprehensive note. Let's do `web_fetch` on the GlobeNewswire release. First, let's state the intent and fetch.I will fetch the GlobeNewswire press release on the FDA's approval of the first generic version of Xofluza (baloxavir marboxil) to obtain precise facts, quotes, and the manufacturer's details.

This is very clear. The FDA approved Norwich Pharmaceuticals, Inc.'s generic baloxavir marboxil (Xofluza) on June 18, 2026 (or June 17, as per Reuters, but the press release date is June 18). Let's see: baloxavir marboxil is a cap-dependent endonuclease inhibitor. It is the first generic version of Xofluza approved. This is a major public health milestone ahead of the 2026-2027 flu season. Let's search for other news. What about the "ACTIV-6 trial metformin long COVID risk"? Let's search for this to see if there is a new publication or announcement. I will search for "metformin long COVID ACTIV-6 June 2026". Let's do a search.I will search for the recent findings of the ACTIV-6 trial regarding metformin and long COVID to see if there is a new study published in June 2026 and what the key results are.

Let's fetch the Drug Topics article or Pharmacy Times article to understand the details. Let's do `web_fetch` on `https://www.drugtopics.com/view/metformin-cuts-long-covid-risk-by-half-in-new-activ-6-trial-results`. First, let's state the intent and fetch.I will fetch the Drug Topics article on the ACTIV-6 trial results to get the specific details, quotes, and context of how metformin reduces long COVID risk.

This is a very notable science/health story. The ACTIV-6 randomized trial results were published in *Clinical Infectious Diseases* on June 4, 2026, with a press release from the University of Minnesota Medical School on June 11, 2026. It showed that starting metformin during acute infection resulted in a 50% relative reduction in clinician-diagnosed long COVID at 6 months (0.56% vs 1.17%), replicating the earlier COVID-OUT trial. This is a solid, clean, and new science/health story that we can write a note on. Let's do some more searches on other active watches to see if anything has happened recently. For example, let's search for: - "Amgen Tavneos" - there is a watch: "Amgen Tavneos FDA hearing submission and public docket close" (fire date June 29, 2026). So it's still upcoming. Let's see if there are any recent updates. - "Zepzelca" (lurbinectedin) - we have a note `zepzelca-phase3-lagoon-sclc-failure` and `zepzelca-lagoon-sclc-trial-failure`. Wait! These are duplicate notes: `zepzelca-phase3-lagoon-sclc-failure` and `zepzelca-lagoon-sclc-trial-failure`! Let's check the difference. We can check `read_notes` to see what is in each. We see that `zepzelca-phase3-lagoon-sclc-failure` was updated on June 19, 2026, and `zepzelca-lagoon-sclc-trial-failure` was updated on June 16, 2026. Let's see if there is any new regulatory decision or statement on Zepzelca in the last week. Let's search for "Zepzelca FDA" or "lurbinectedin FDA June 2026". - "H5N1 bird flu" - let's search for "H5N1 bird flu June 2026" or "Moderna bird flu vaccine". - "New World screwworm" - let's search for "New World screwworm June 2026". - "MFlusiva" - Moderna's mRNA flu vaccine. The watch says: "FDA regulatory decision on Moderna's mFlusiva mRNA flu vaccine" (PDUFA date August 5, 2026). Let's see if there are other updates on mFlusiva. - "Belite Bio tinlarebant" - there is a watch: "FDA filing acceptance and PDUFA date for Belite Bio's tinlarebant" (expected early August 2026). - Let's search for "FDA approval June 2026" to see if there are other major approvals this week. Let's run these searches. I will state my intent and execute.I will perform a search for recent updates on several of our active watches, including FDA decisions, H5N1 bird flu, and New World screwworm developments in June 2026.

Excellent. The failure of the Zepzelca Phase 3 LAGOON trial is already covered in our existing notes (`zepzelca-phase3-lagoon-sclc-failure` and `zepzelca-lagoon-sclc-trial-failure`). But wait! The article from Clinical Trial Vanguard: "Jazz and PharmaMar Just Ran Out of Runway: Zepzelca’s Confirmatory Failure Is an Accelerated Approval System Under Stress" (June 16, 2026) seems very substantive. Let's search for other news. What about "first-ever cat-to-human H5N1 transmission" or "H5N1 bird flu June 2026"? Let's do a search on H5N1 bird flu. I want to see if there are any new human cases or developments in the last week. Let's do a search.I will search for the latest developments regarding H5N1 bird flu, including new human cases, USDA or CDC updates, and vaccine progress.

This is very interesting. Wait, let's explore "NJ & RI Both Report H5N1 in Live Markets" from June 14-15, 2026. Let's see what that blog post or news says. Live bird markets in New Jersey and Rhode Island are reporting H5N1 detections. Let's do a search for "H5N1 live markets Rhode Island New Jersey June 2026". Also, the "Idaho Health HAN: Consider Avian Influenza A (H5N1) in Patients with Dairy Cattle or Poultry Exposure" from June 18/19, 2026. Let's search for "H5N1 live market Providence" or "H5N1 New Jersey live market". I will state my intent and search.I will search for the details on the H5N1 detections in live bird markets in Rhode Island and New Jersey to see if there is a new epidemiological pattern or public health action being taken.

Let's fetch `https://afludiary.blogspot.com/2026/06/nj-ri-both-report-h5n1-in-live-markets.html` to read about the live market detections. This is a very recent development in the H5N1 outbreak (the emergency response has been scaled down, but scattered outbreaks continue, and live markets are a major node of transmission risk). I will fetch this page.I will fetch the blog post from Avian Flu Diary (a highly reputable infectious disease surveillance blog) to read about the new H5N1 detections in live bird markets in Rhode Island and New Jersey.

This is a fantastic update on H5N1 bird flu! It shows that despite the CDC deactivating its emergency response, active surveillance and outbreaks continue. Specifically, live bird markets in Passaic, NJ and Providence, RI (Antonelli Poultry) tested positive for H5N1 in mid-June 2026. In Providence, 445 birds were euthanized, and the health department is monitoring staff. In Passaic, NJ, the live market outbreak matches wastewater positives in the area. This represents our 20th live market outbreak in the U.S. in 2026. We should update our existing note `cdc-ends-h5n1-bird-flu-emergency-response` (or write a new note if it's a separate angle, but let's see. The slug `cdc-ends-h5n1-bird-flu-emergency-response` is about CDC ending the emergency response as surveillance scales down. This live market news shows that despite the scaling down of the emergency response, active local outbreaks and surveillance continue to detect H5N1 in critical nodes like urban live bird markets). Let's reuse `cdc-ends-h5n1-bird-flu-emergency-response` to update it and show that the outbreak is still active and evolving, particularly in urban live bird markets (NJ and RI) which represent the 20th live market outbreak in the U.S. in 2026. Wait, let's also check if there is any update on the New World screwworm outbreak. Let's do a search for "New World screwworm outbreak June 2026". We had a note: `new-world-screwworm-us-outbreak` which was updated on June 14, 2026. Let's see if there are any new cases or developments since then. Let's do a search.I will search for any recent updates on the New World screwworm outbreak in the U.S. Southwest to see if any new cases have been reported since mid-June.

This is a major and highly consequential public health/science/agricultural story! The New World screwworm outbreak has risen to 12 confirmed cases (up from 7 in our previous note). It has spread beyond the initial contamination zones. It is sparking a political blame game, and there is a lot of scrutiny on the USDA. Let's look at the sources: - "US screwworm cases rise as outbreak spreads beyond initial contamination zones" (The Guardian, June 16, 2026). - "USDA faces scrutiny as screwworm cases mount" (Washington Post, June 19, 2026). Let's fetch this or the Guardian article. Let's see if we can search for the Washington Post article or fetch the Guardian article. Let's do `web_fetch` on `https://www.theguardian.com/us-news/2026/jun/16/screwworm-cases-rise-outbreak-spreads`. First, let's state the intent and fetch.I will fetch the Guardian article on the rising New World screwworm cases (now 12 confirmed cases) and their spread beyond initial zones, which is a major update to our existing note `new-world-screwworm-us-outbreak`.

Ah, the web_search tool budget is spent! That is fine, we have enough high-quality information to write two very strong updates, and possibly resolve or register threads/watches. Let's see what we have: 1. **Gilead sNDA Acceptance for Once-Weekly Oral Yeztugo (lenacapavir):** - On June 15, 2026, Gilead announced that the FDA accepted its sNDA for Yeztugo (lenacapavir) 300-mg tablet as a potential once-weekly oral formulation for HIV PrEP. - PDUFA date is February 2, 2027. - This directly updates our existing note `gilead-merck-lenacapavir-once-weekly-hiv-advances` (or we can update it under that slug). Let's review the slug `gilead-merck-lenacapavir-once-weekly-hiv-advances`. Yes, we can update this note! - Wait, we also have a watch: "FDA regulatory decision on Gilead's once-weekly oral Yeztugo for HIV PrEP" (ID: `019ed29e-a6ae-790c-8ca3-dd606cdeec86`). This watch fires on the regulatory decision (Feb 2, 2027) so it is not resolved yet, but we have updated details on it. 2. **FDA Approves First Generic of Xofluza (baloxavir marboxil):** - On June 18, 2026, the FDA approved the first generic version of Roche's Xofluza (baloxavir marboxil) tablets (developed by Norwich Pharmaceuticals, Inc.) for acute uncomplicated influenza and post-exposure prophylaxis in patients 5 years and older. - This is a new, major public health milestone ahead of the 2026-2027 flu season. - Let's mint a new slug: `fda-approves-first-generic-xofluza-baloxavir-marboxil`. 3. **ACTIV-6 Trial Metformin Long COVID Risk Reduction:** - In June 2026, a paper published in *Clinical Infectious Diseases* (June 4, 2026) and announced on June 11, 2026, by the University of Minnesota Medical School detailed that starting metformin during acute infection resulted in a 50% relative reduction in clinician-diagnosed long COVID at 6 months (0.56% vs 1.17%), replicating the earlier COVID-OUT trial. - This is a very notable breakthrough. Let's mint a new slug: `metformin-reduces-long-covid-risk-activ6-trial`. 4. **New World Screwworm Outbreak Escalates:** - The number of confirmed animal cases of the flesh-eating New World screwworm has risen to 12 across Texas and New Mexico (up from 7). - This has spread beyond initial contamination zones (counties include Sutton, Edwards, Tom Green, Gillespie, La Salle, Zavala in Texas, and Lea in New Mexico). - The USDA has released 4 million sterile flies on the ground and 4 million in the air. - Pennsylvania has issued a precautionary quarantine on livestock imports from affected areas. - This updates our existing note `new-world-screwworm-us-outbreak`. Let's update that note! 5. **H5N1 Bird Flu Outbreak - Live Bird Market Detections:** - Despite CDC deactivating its emergency response, H5N1 continues to pop up. - In mid-June 2026, live bird markets in Passaic, NJ and Providence, RI (Antonelli Poultry) tested positive for H5N1. - In Providence, 445 asymptomatic birds (chickens, ducks) were euthanized, and RIDOH is monitoring staff. - These are the 20th and subsequent live market outbreaks in the US in 2026. - This updates our existing note `cdc-ends-h5n1-bird-flu-emergency-response`. Let's update that note! Wait, let's write these notes! Let's double-check the rules: - Carry 1-2 representative verbatim quotes, copied exactly, each kept with the link it came from. - No YAML frontmatter. First heading is `# <Title>`. - Use wikilinks to link other findings, like `[[cdc-ends-h5n1-bird-flu-emergency-response]]`. - Stable slugs. Let's write the notes one by one. ### First Note: `gilead-merck-lenacapavir-once-weekly-hiv-advances` Let's see if we should update this note. Yes, the previous note was `gilead-merck-lenacapavir-once-weekly-hiv-advances`. We will update it. Let's draft the note. Wait, let's look at what is already in `gilead-merck-lenacapavir-once-weekly-hiv-advances` from the preview: `The landscape of HIV treatment and prevention is shifting toward long-acting oral regimens, anchored by Gilead Sciences' first-in-class capsid inhibitor lenacapavir. In June 2026, two major...` We will rewrite the note to include the June 15, 2026 announcement that the FDA accepted the sNDA and set a PDUFA date of February 2, 2027. Wait! Is there an existing note on lenacapavir? Yes: `gilead-merck-lenacapavir-once-weekly-hiv-advances` and `islatravir-lenacapavir-once-weekly-hiv-phase3` are related, but `gilead-merck-lenacapavir-once-weekly-hiv-advances` is the most recent (updated June 16, 2026). Let's use `gilead-merck-lenacapavir-once-weekly-hiv-advances` to update it. Let's carefully construct the first note body. Verbatim quote from the EATG press release: > "Gilead Sciences, Inc. (Nasdaq: GILD) today announced the U.S. Food and Drug Administration (FDA) accepted its supplemental New Drug Application (sNDA) for Yeztugo ® (lenacapavir) 300-mg tablet as a potential once-weekly (QW) oral formulation for the prevention of HIV as pre-exposure prophylaxis (PrEP). The FDA has assigned a Prescription Drug User Fee Act (PDUFA) action date of February 2, 2027." From: `https://www.eatg.org/hiv-news/press-release-fda-accepts-gileads-application-for-investigational-once-weekly-oral-yeztugo-potentially-the-first-long-acting-pill-for-hiv-prevention/` Let's write the note `gilead-merck-lenacapavir-once-weekly-hiv-advances`. I will state my intent and write it.I will update the existing note `gilead-merck-lenacapavir-once-weekly-hiv-advances` to record the FDA's formal acceptance of Gilead's sNDA for once-weekly oral Yeztugo (lenacapavir) for HIV PrEP, locking in the PDUFA date of February 2, 2027.

Now, let's write the note on the first generic of Xofluza (baloxavir marboxil), which was approved by the FDA on June 18, 2026. Let's name this slug: `fda-approves-first-generic-xofluza-baloxavir-marboxil`. Let's review the details: - Approved on June 18, 2026. - First generic of Xofluza (baloxavir marboxil) tablets. - Manufacturer: Norwich Pharmaceuticals, Inc. - Indication: Single-dose treatment of acute uncomplicated influenza and post-exposure prophylaxis in patients 5 years and older. - Quote: > "Today’s approval marks a meaningful milestone for the treatment of influenza. Expanding patient access to drugs and improving their ease of use are critical public health imperatives, particularly given that influenza alone accounts for millions of illnesses in the U.S. each year." > — Dr. Iilun Murphy, Director of the Office of Generic Drugs in FDA’s CDER. Let's write this note. I will state my intent and execute.I will write a new note under the slug `fda-approves-first-generic-xofluza-baloxavir-marboxil` about the FDA's landmark approval of the first generic version of Xofluza (baloxavir marboxil) developed by Norwich Pharmaceuticals, Inc. ahead of the 2026-2027 flu season.

Now let's write the note on the ACTIV-6 trial showing that metformin reduces long COVID risk by half. Let's name this slug: `metformin-reduces-long-covid-risk-activ6-trial`. Let's review the details: - Published in *Clinical Infectious Diseases* on June 4, 2026. - University of Minnesota Medical School press release on June 11, 2026. - The ACTIV-6 randomized trial evaluated nearly 3,000 outpatient adults aged 30+ with mild-to-moderate COVID-19 across 90 US sites. - Replicated findings of the earlier COVID-OUT trial. - Relative risk reduction of 50% in clinician-diagnosed Long COVID (PASC) at 6 months (0.56% in the metformin group vs 1.17% in the placebo group), despite a negative primary endpoint based on total self-reported symptoms. - Dosing: 14-day up-titration to 1500 mg/day (500mg on day 1, 500mg BID for 4 days, then 1500mg split for 9 days). No lactic acidosis or significant hypoglycemia. - Biological mechanism: anti-inflammatory, lowers viral load, inhibits mTORC1 signaling in the gut, promotes gut barrier integrity and short-chain fatty acids. - Quotes: > "This trial provides additional evidence that treating acute infection with this intervention that acts on metabolic health can reduce the likelihood of developing long COVID. The finding is particularly important because metformin is inexpensive, globally available, and has decades of clinical use supporting its safety." > — Dr. Carolyn Bramante, Assistant Professor at the University of Minnesota Medical School Let's write this note. I will state my intent and execute.I will write a new note under the slug `metformin-reduces-long-covid-risk-activ6-trial` detailing the Phase 3 ACTIV-6 trial findings published in June 2026, which show that starting metformin during acute COVID-19 infection halves the risk of clinician-diagnosed long COVID.

Now let's update the New World screwworm outbreak note. The existing note slug is `new-world-screwworm-us-outbreak`. Let's see what is in the existing note from the preview: `The outbreak of the highly destructive, flesh-eating New World screwworm (Cochliomyia hominivorax) in the U.S. Southwest has escalated to seven confirmed cases across Texas and New Mexico. The…` We will update this note with the new data: - Detections have risen to 12 confirmed cases (11 active, 1 inactive). - Sutton County, Texas has a new case in a sheep (reported June 12, 2026). - Other affected counties: Edwards, Tom Green, Gillespie, La Salle, and Zavala in Texas, and Lea County in New Mexico. - Outbreak has spread beyond the initial contamination zones. - Sid Miller (Texas Agriculture Commissioner) is demanding immediate expansion of the Screwworm Adult Suppression System (Swass), which uses targeted bait to kill fertile adult flies, rather than relying solely on sterile fly releases. - Brooke Rollins (U.S. Agriculture Secretary) stated that the government has released 4 million sterile flies on the ground and 4 million in the air. - Pennsylvania has issued a precautionary quarantine order on livestock imported from affected areas to prevent the spread. Let's write this update. I will state my intent and execute.I will update the existing note `new-world-screwworm-us-outbreak` to capture the rise in cases to 12, the geographic spread across Texas and New Mexico, the political and strategic debate over control measures (including the demand for Swass), and Pennsylvania's precautionary quarantine.

Now let's write the update on H5N1 bird flu and live bird markets. The existing note is `cdc-ends-h5n1-bird-flu-emergency-response`. Let's see what is in it from the preview: `In June 2026, the U.S. Centers for Disease Control and Prevention (CDC) deactivated its emergency response to the highly pathogenic H5N1 avian influenza outbreak, ending a high-priority public health…` Let's update this note to show that although the CDC deactivated its emergency response and scaled down surveillance, local outbreaks continue to be detected in critical urban transmission nodes like live bird markets (LBMs) in the Northeast. Specifically: - In mid-June 2026, H5N1 was detected in live bird markets in Passaic, New Jersey, and Providence, Rhode Island (Antonelli Poultry). - This represents Rhode Island's first confirmed domestic bird case of avian influenza in 2026, and the 20th live market outbreak in the U.S. in 2026 (out of 77 since 2022). - In Providence, a routine quarterly USDA inspection detected asymptomatic H5-positive poultry (chickens, ducks) imported from out-of-state. State Veterinarian Scott Marshall oversaw the humane euthanasia of 445 birds, and the market was temporarily closed. - The Rhode Island Department of Health (RIDOH) is monitoring staff for symptoms, and has advised consumers who bought poultry killed/dressed at the market between June 9 and June 12 to double-bag and discard it. - In Passaic, New Jersey, the USDA reported a live market outbreak, which is particularly notable because Passaic is one of only three wastewater monitoring sites in the U.S. currently reporting HPAI H5 positives in recent CDC reports. - These events highlight that live bird markets remain a potent risk factor for animal-to-human transmission, even as federal emergency efforts are dialed back. Let's write this update. I will state my intent and execute.I will update the existing note `cdc-ends-h5n1-bird-flu-emergency-response` to show that despite the CDC scaling down its emergency response, H5N1 remains highly active, with new outbreaks detected in northeastern live bird markets (NJ and RI) that represent critical risk vectors for animal-to-human transmission.

This is excellent! I have successfully written/updated 4 notes: 1. Updated `gilead-merck-lenacapavir-once-weekly-hiv-advances` 2. Created a new note `fda-approves-first-generic-xofluza-baloxavir-marboxil` 3. Created a new note `metformin-reduces-long-covid-risk-activ6-trial` 4. Updated `new-world-screwworm-us-outbreak` 5. Updated `cdc-ends-h5n1-bird-flu-emergency-response` Wait, let's review the active threads/watches. Let's see if we can resolve any threads. Wait! Let's check `list_threads` results again. We have: - `019ed29e-a6ae-790c-8ca3-dd606cdeec86`: "FDA regulatory decision on Gilead's once-weekly oral Yeztugo for HIV PrEP". This watch is for the regulatory decision, which is on Feb 2, 2027. It is not resolved yet, so we shouldn't resolve it. Wait, is there any thread we can resolve? No, we don't have an open thread for the sNDA acceptance itself (it was a watch for the decision). Let's check if there are any other watches we should register. Wait! We have several forward-looking things: - The PDUFA date for Norwich's generic Xofluza? No, it has already been approved. - The PDUFA date for Gilead's once-weekly oral Yeztugo is Feb 2, 2027. We already have a watch for that: `019ed29e-a6ae-790c-8ca3-dd606cdeec86` ("FDA regulatory decision on Gilead's once-weekly oral Yeztugo for HIV PrEP"). - What about the ACTIV-6 trial or metformin? Metformin is already off-patent and widely used, so there isn't a specific FDA approval watch for it for long COVID yet, but we should monitor if any guidelines or FDA approvals are sought for long COVID. Let's see if there is any other specific forward-looking item. Wait, let's register a watch for the USDA's screwworm response or any other major catalyst. Let's see: we already have a watch for the USDA's $750 million sterile fly production facility in Texas (`019ec32d-6d1a-725d-9d28-251b38e8d928`). We also have a watch for the FDA's decision on Moderna's mFlusiva (`019edcf0-1d32-70e1-9a3e-6825808b2370`) with fire date August 5, 2026. And we have a watch for Amgen's Tavneos FDA hearing submission on June 29, 2026 (`019ec855-5381-7936-a3b6-a40d207e679d`). Let's double check if there are other threads we should record. No, we have covered all the major new developments very thoroughly. Let's call `finish_cycle` to complete this research cycle! Wait, let's look at the parameters of `finish_cycle`: - `no_findings_reason`: only when you wrote no findings this cycle. Since we *did* write findings, we should omit or pass empty string. Let's call `finish_cycle`. I will state my intent and execute.I will call `finish_cycle` to conclude this research cycle, as we have successfully researched and documented all the latest major science, medicine, and public health updates.

I have successfully completed the research cycle for this topic. Here is a summary of the findings and updates recorded during this cycle: ### 1. FDA Accepts Gilead's sNDA for Once-Weekly Oral Yeztugo (lenacapavir) for HIV PrEP * **What Happened:** On June 15, 2026, Gilead Sciences announced that the FDA formally accepted its supplemental New Drug Application (sNDA) for **Yeztugo (lenacapavir) 300-mg tablets** as a potential once-weekly oral formulation for HIV pre-exposure prophylaxis (PrEP). * **Significance:** If approved, Yeztugo would become the world's first long-acting oral PrEP option. The FDA has assigned a PDUFA target action date of **February 2, 2027**. * **Note Updated:** `gilead-merck-lenacapavir-once-weekly-hiv-advances` (reflects the official FDA acceptance and PDUFA date). ### 2. FDA Approves First Generic Version of Roche's Single-Dose Flu Antiviral Xofluza * **What Happened:** On June 18, 2026, the FDA approved the first generic version of Genentech/Roche's **Xofluza (baloxavir marboxil)** tablets. The generic approval was granted to **Norwich Pharmaceuticals, Inc.** * **Significance:** Baloxavir marboxil is a first-in-class, cap-dependent endonuclease inhibitor. Unlike traditional multi-day antivirals, it requires only a single oral dose. This approval enhances access to affordable single-dose flu treatments and prophylaxis ahead of the 2026–2027 flu season. * **New Note Written:** `fda-approves-first-generic-xofluza-baloxavir-marboxil` ### 3. Metformin Halves Long COVID Risk in Phase 3 ACTIV-6 Trial * **What Happened:** Newly published results from the large-scale **ACTIV-6 (NCT04885530)** randomized trial in *Clinical Infectious Diseases* (June 4, 2026) show that starting a 14-day regimen of immediate-release metformin within seven days of acute symptom onset results in a **50% relative reduction** in clinician-diagnosed long COVID (PASC) at six months (0.56% in the metformin group vs 1.17% in the placebo group). * **Significance:** These findings replicate the earlier COVID-OUT trial. Metformin is inexpensive, widely available, and has a well-established safety profile. Mechanistically, it is believed to act as a host-directed anti-inflammatory, preserving gut epithelial integrity by inhibiting SARS-CoV-2-induced mTORC1 signaling and lowering viral replication. * **New Note Written:** `metformin-reduces-long-covid-risk-activ6-trial` ### 4. New World Screwworm Outbreak Escalates to 12 Cases * **What Happened:** Confirmed animal infestations of the flesh-eating New World screwworm (*Cochliomyia hominivorax*) in the U.S. Southwest have risen to **12 cases** across Texas and New Mexico (up from 7). Sutton County, West Texas, recorded a new case in a sheep on June 12, 2026. * **Significance:** The geographic spread has triggered a political debate. Texas Agriculture Commissioner Sid Miller is demanding the immediate deployment of the **Screwworm Adult Suppression System (Swass)**—which uses pesticide-laced bait to kill fertile adult flies—rather than relying solely on the USDA's sterile fly releases (SIT). Meanwhile, Pennsylvania has issued a precautionary quarantine on livestock imports from affected areas to prevent nationwide spread. * **Note Updated:** `new-world-screwworm-us-outbreak` ### 5. H5N1 Bird Flu Outbreaks Detected in Northeastern Live Bird Markets * **What Happened:** Despite the CDC deactivating its emergency response to the H5N1 outbreak, active local surveillance continues to detect the virus in critical urban nodes. In mid-June 2026, live bird markets in **Passaic, New Jersey**, and **Providence, Rhode Island** (Antonelli Poultry) tested positive for H5N1. * **Significance:** In Providence, approximately 445 asymptomatic birds were euthanized. In Passaic, NJ, the market outbreak directly correlates with local wastewater monitoring, which is one of only three sites in the U.S. currently reporting HPAI H5 positives. These events highlight that urban live bird markets remain key vectors for animal-to-human transmission. * **Note Updated:** `cdc-ends-h5n1-bird-flu-emergency-response`